Recorded fact · drug.label_indication
drug.label_indication for encorafenib|colorectal-cancer
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact f8c57235 resolves to.
The record
| Fact id | f8c5723538df7c60bf2f1cd1 |
|---|---|
| Entity | drug: encorafenib|colorectal-cancer |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260226 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
Colorectal Cancer (CRC) • in combination with cetuximab and fluorouracil-based chemotherapy, for the treatment of adult patients with metastatic colorectal cancer (mCRC) with a BRAF V600E mutation, as
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 1a01b24b1e1ed1aad8cfe2ecd4bbd465aa34c415c2feab7636251d2fb069fb63.
The value
{
"ingredient": "Encorafenib",
"conditionId": "colorectal-cancer",
"conditionName": "Colorectal cancer",
"matchedAlias": "Colorectal Cancer",
"context": "indication",
"brand": "BRAFTOVI",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "235dfc38-0f0b-4037-b501-7a9f4294740c",
"labelEffectiveTime": "20260226",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 32e0bf88228270fc5b1afc5f3a2907d56601de8c0024052a2eb4a0967bdfd531.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.